Hap Trading, LLC Compugen LTD Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	BUY	$1.57 - $3.33 $5,338 - $11,322	3,400 Added 29.06%	15,100 $1,000
Q1 2022 May 12, 2022	BUY	$2.76 - $4.64 $3,863 - $6,496	1,400 Added 13.59%	11,700 $1,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $42,127 - $73,748	10,300 New	10,300 $4,000
Q2 2021 Aug 11, 2021	SELL	$6.87 - $9.16 $186,177 - $248,236	-27,100 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$7.67 - $13.77 $3,068 - $5,508	-400 Reduced 1.45%	27,100 $19,000
Q4 2020 Feb 16, 2021	BUY	$12.07 - $17.95 $331,925 - $493,625	27,500 New	27,500 $50,000

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.